CELLDEX THERAPEUTICS INC NEW

Ticker: CLDX CUSIP: 15117B202 Class: Common Stock

KENNEDY CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000884589)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024

Shares 33,586 Value ($000) $1,410 Avg Close $41.06 Range $34.65 - $53.18

Q4 2023

Shares 62,172 Value ($000) $2,466 Avg Close $29.41 Range $22.11 - $41.47

Q3 2023

Shares 87,394 Value ($000) $2,405 Avg Close $31.35 Range $24.89 - $38.33

Q2 2023

Shares 87,228 Value ($000) $2,960 Avg Close $33.70 Range $29.68 - $39.29

Q1 2023

Shares 81,366 Value ($000) $2,928 Avg Close $43.15 Range $33.83 - $48.40

Q4 2022

Shares 81,319 Value ($000) $3,624 Avg Close $35.70 Range $27.01 - $46.04

Q3 2022

Shares 81,350 Value ($000) $2,287 Avg Close $30.66 Range $21.65 - $38.52

Q2 2022

Shares 24,316 Value ($000) $656 Avg Close $29.04 Range $19.85 - $37.95

Q1 2022

Shares 24,517 Value ($000) $835 Avg Close $31.97 Range $26.47 - $39.84

Q4 2021

Shares 28,158 Value ($000) $1,088 Avg Close $43.58 Range $35.00 - $57.20

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2024	33,586	$1,410	$41.06	$34.65 - $53.18
Q4 2023	62,172	$2,466	$29.41	$22.11 - $41.47
Q3 2023	87,394	$2,405	$31.35	$24.89 - $38.33
Q2 2023	87,228	$2,960	$33.70	$29.68 - $39.29
Q1 2023	81,366	$2,928	$43.15	$33.83 - $48.40
Q4 2022	81,319	$3,624	$35.70	$27.01 - $46.04
Q3 2022	81,350	$2,287	$30.66	$21.65 - $38.52
Q2 2022	24,316	$656	$29.04	$19.85 - $37.95
Q1 2022	24,517	$835	$31.97	$26.47 - $39.84
Q4 2021	28,158	$1,088	$43.58	$35.00 - $57.20